Evidence map›Paper›PMID 40143603›Full record

ArticleThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics2025

The Need for Prospective Integrity Standards for the Use of Generative AI in Research.

Kayte Spector-Bagdady

Abstract read
In one paragraph

Article in The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Plastic and reconstructive surgery. Global open · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kayte Spector-BagdadyUniversity of Michigan, Ann Arbor, MI, United States.ORCID https://orcid.org/0000-0002-5851-6224

Funding

The National Dementia Workforce StudyU54AG084520 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DONOVAN T MAUST · 2023 to 2026
$81.0M
Hospitals Sharing Patient Data and Biospecimens with Commercial Entities: Evidence-Based Translation to Improved PracticeR01TR004244 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SPECTOR-BAGDADY, KAYTE KELLEHER · 2022 to 2025
$1.9M
Greenwall Foundation Faculty ScholarsNCATS NIH HHS R01 TR004244NIA NIH HHS U54 AG084520NIA NIH HHS U54AG084520
6 · The paper itself

Abstract

The federal government has a long history of trying to find the right balance in supporting scientific and medical research while protecting the public and other researchers from potential harms. To date, this balance has been generally calibrated differently across contexts - including in clinical care, human subjects research, and research integrity. New challenges continue to face this disparate model of regulation, including novel Generative Artificial Intelligence (GenAI) tools. Because of potential increases in unintentional fabrication, falsification, and plagiarism using GenAI - and challenges establishing both these errors and intentionality in retrospect - this article argues that we should instead move toward a system that sets accepted community standards for the use of GenAI in research as prospective requirements.

Indexed as

ethicsintegrityresearch

Identifiers

PMID40143603
PMCPMC12179527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.